Auflistung nach Autor "Korantzis, I."
Anzeige der Dokumente 1-4 von 4
-
Analysis of SLC40A1(Ferroportin 1) gene at mrna level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV
Speletas, M.; Kioumi, A.; Loules, G.; Kalala, F.; Katodritou, E.; Tsitouridis, I.; Hytiroglou, P.; Christakis, J.; Korantzis, I.; Germenis, A. (2007) -
Pneumonia caused by Candida krusei and Candida glabrata in a patient with chronic myeloid leukemia receiving imatinib mesylate treatment
Speletas, M.; Vyzantiadis, T. A.; Kalala, F.; Plastiras, D.; Kokoviadou, K.; Antoniadis, A.; Korantzis, I. (2008)In this report we describe a patient suffering from chronic myeloid leukemia (CML), who was treated for 4.5 years with imatinib and developed pneumonia caused by two Candida species, i.e., C. krusei and C. glabrata. The ... -
TLR4 single nucleotide polymorphisms and thrombosis risk in patients with myeloproliferative disorders
Speletas, M.; Liadaki, K.; Kalala, F.; Daiou, C.; Katodritou, E.; Mandala, E.; Korantzis, I.; Ritis, K.; Zintzaras, E.; Germenis, A. E. (2008) -
Treatment with lenalidomide for patients with myelodysplastic syndromes (MDS): report of the Hellenic experience on 73 patients. A retrospective analysis of the Hellenic MDS Study Group
Symeonidis, A.; Galanopoulos, A.; Hatzimichael, E.; Kouraklis, A.; Korantzis, I.; Kartasis, Z.; Giannakoulas, N.; Michali, E.; Kokkini, G.; Vagia, M.; Kotsopoulou, M.; Pappa, V.; Papadaki, E.; Bourantas, K.; Matsouka, P.; Anagnostopoulos, N.; Zoumbos, N.; Hellenic, M. D. S. Study Grp (2009)